IMAX vs Xperi
IMAX and XPER side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IMAX and XPER compare
IMAX is the larger company, worth 8.9 times as much as Xperi ($2.6B against $296M).
IMAX grew revenue faster over the last twelve months (28.1% versus 1.1% for Xperi).
IMAX scores higher on the StockData Score (14 against 3 for Xperi), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IMAX | XPER |
|---|---|---|
| Size and price | ||
| Market cap | $2.6B | $296M |
| Share price | $48.29 | $6.07 |
| Change, 1 year | 34.4% | −7.9% |
| Change, 5 years | 164% | −68.2% |
| Beta (5Y) | 0.70 | 0.71 |
| Employees | 679 | 250 |
| StockData Score | ||
| Total score | 14 (better) | 3 |
| Valuation score | 5 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.9× | – |
| P/S | 5.5× | 0.6× (better) |
| P/B | 5.4× | – |
| EV/EBITDA | 12.5× | – |
| P/FCF | 18.1× | – |
| FCF yield | 5.5% (better) | −0.21% |
| Fair value | $79.21 | – |
| Margin of safety | 39.0% | – |
| Growth | ||
| Revenue growth (TTM) | 28.1% (better) | 1.1% |
| Revenue growth, 5Y average | 24.5% (better) | 3.6% |
| Net income growth (TTM) | 239% | – |
| EPS growth (TTM) | 225% (better) | −500% |
| Profitability | ||
| Gross margin | 63.5% | – |
| Operating margin | 26.8% (better) | −1.7% |
| Net margin | 27.7% | – |
| FCF margin | 30.2% (better) | −0.14% |
| Return on equity | 31.9% | – |
| Return on invested capital | 52.9% | – |
| Financial health | ||
| Interest coverage | 17.4× (better) | −2.9× |
| Current ratio | – | 2.38 |
| Altman Z-score | 4.34 (better) | −0.17 |
| Piotroski F-score | 7 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 93.7% | 93.2% |
| Held by insiders | 21.6% | 5.9% |
| Insider net buying, 12 months | −$70.2M | – |
| Short interest, % of float | 15.6% | 12.3% |
Go deeper
- IMAX stock overview
- IMAX income statement
- IMAX valuation and score
- XPER stock overview
- XPER income statement
- XPER valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.